# ARTEMIS-008 (NCT06498479)

> ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06498479
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Hansoh BioMedical R&D Company
- Conditions: Small Cell Lung Cancer
- Interventions: HS-20093; Topotecan
- Enrollment: 461
- Primary outcome: Overall survival

## Indexed commentary on ARTEMIS-008 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 73
- Podcasts: 7
- YouTube: 4
- X videos: 3
- Bluesky threads: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=artemis-008-nct06498479

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT06498479", "email": "<work email>"}; the inbox owner confirms by the emailed link.